Elsevier

Auris Nasus Larynx

Volume 50, Issue 2, April 2023, Pages 292-298
Auris Nasus Larynx

Otolaryngology consultations for COVID-19 patients: A retrospective cohort study of indications, interventions, and considerations

https://doi.org/10.1016/j.anl.2022.08.002Get rights and content

Abstract

Objective

To identify differences in inpatient otolaryngology consultations and interventions for patients based on COVID-19.

Methods

Records were reviewed for all patients for whom otolaryngology was consulted at a high-volume tertiary care hospital from April 30, 2020 to October 1, 2020. Demographic information, length of stay, COVID-19 status, indication for consultation, and otolaryngology interventions were recorded. Statistical analysis was performed using R software.

Results

Bleeding composed a significantly higher proportion of otolaryngology consults in COVID-19 positive patients (28% vs. 8.4%, p<0.0001). Management of bleeding was the most common procedure performed in positive patients (n=37, 35%), and they had a higher median number of interventions performed when compared to bleeding patients who tested negative (1, IQR 1-2 vs. 1, IQR 0-1, p=0.04). COVID-19 positive patients with bleeding were more likely to expire than those with other indications for otolaryngology consultation (50% vs. 7%, p<0.001).

Conclusion

Bleeding and associated interventions comprised the predominant discrepancy between COVID-19 positive and negative patients in our cohort. We encourage routine use of simple and cost-effective methods to decrease risk of bleeding.

Keywords

Otolaryngology consults
Otorhinolaryngologic diseases
Covid-19
Epistaxis
Anticoagulation

Cited by (0)

#

These authors contributed equally to this work.

View Abstract